A significant discovery in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This crucial tumor protector protein is frequently inactivated in various types of malignancies, causing https://agency-social.com/story7007078/mini-antibodies-reactivate-p53-the-potential-pathway-for-cancer-treatment